Skip to main content
. 2022 Nov 23;77(3):342–347. doi: 10.1038/s41430-022-01241-z

Table 3.

Comparison of the changes in serum 25-hydroxyvitamin D levels between the experimental and control groups.

25-hydroxyvitamin D (ng/ml) Experimental group (n = 64) Control group (n = 72) p valuea p valueb
Mean ± SD Mean ± SD
Baseline 21.15 ± 10.19 22.04 ± 10.42 0.618
Week 2 21.40 ± 9.85 20.97 ± 10.13
Δ 0.25 ± 3.10 −1.07 ± 2.68 0.009 0.018
p valuec 0.523 0.001
Week 4 21.90 ± 9.58 20.28 ± 10.07
Δ 0.75 ± 3.98 −1.75 ± 3.04 <0.001 <0.001
p-valuec 0.139 <0.001
Week 6 22.14 ± 9.53 20.33 ± 9.69
Δ 0.99 ± 4.97 −1.70 ± 3.64 0.001 0.002
p valuec 0.117 <0.001

Data are presented as mean ± standard deviation.

Δ represents a change from baseline.

SD standard deviation.

aIndependent t-test was performed to examine between-group differences.

bAnalysis of covariance adjusted for age, sex, time spent on outdoor activities, dietary vitamin D intake, compliance with device use, season of study enrollment, and baseline serum 25-hydroxyvitamin D levels, was performed to examine between-group differences.

cPaired t-test was performed to examine within-group differences in changes from baseline serum vitamin D levels.